Sorux to Complete 6th CB Payment on Nov 11... Additional Aribio Share Acquisition and Clinical Funding Planned
Sorux, a company specializing in lighting and eco-friendly businesses, announced on November 3 that it had officially received an investment commitment letter regarding the issuance of its 6th convertible bonds and confirmed the payment date for November 11.
This issuance of convertible bonds is a measure to accelerate Sorux's strategic investments and its entry into the bio sector. The funds raised will be used to: ▲ expand management control by acquiring additional shares in Aribio ▲ support clinical trial funding for an Alzheimer's treatment that is in its final stages.
A Sorux representative stated, "Although the due diligence process took longer than expected and the schedule was partially adjusted, the payment date has now been confirmed based on trust with investors, so the funds will be executed immediately. Through strategic collaboration with Aribio, we aim to enhance both the value of our bio business and Sorux's long-term growth potential."
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Sorux plans to disclose the specific scale of the share acquisition and its capital management plans through a public announcement after the payment is completed.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
